| # | Drug | Count |
|---|---|---|
| 0 | AMBRISENTAN | 36 |
| 1 | ERGOCALCIFEROL | 30 |
| 2 | SILDENAFIL CITRATE | 30 |
| 3 | NIRAPARIB | 25 |
| 4 | TADALAFIL | 25 |
| 5 | EPINEPHRINE | 23 |
| 6 | IBRUTINIB | 23 |
| 7 | ANTIHEMOPHILIC FACTOR (RECOMBINANT), FC FUSION PROTEIN | 22 |
| 8 | EPOPROSTENOL | 22 |
| 9 | TREPROSTINIL | 22 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ANTIHEMOPHILIC FACTOR (RECOMBINANT), FC FUSION PROTEIN | 22 | 0.0058 |
| 1 | C1 ESTERASE INHIBITOR RECOMBINANT | 16 | 0.0025 |
| 2 | ANTIHEMOPHILIC FACTOR (RECOMBINANT), FC-VWF-XTEN FUSION PROTEIN-EHTL | 4 | 0.0024 |
| 3 | LANADELUMAB-FLYO | 6 | 0.0019 |
| 4 | EPOPROSTENOL | 22 | 0.0017 |
| 5 | STERILE WATER FOR INJECTION | 8 | 0.0015 |
| 6 | IDURSULFASE | 5 | 0.0013 |
| 7 | HUMAN C1-ESTERASE INHIBITOR | 18 | 0.0012 |
| 8 | LARONIDASE | 5 | 0.0012 |
| 9 | NIRAPARIB | 25 | 0.0011 |
| # | Drug class | Count |
|---|---|---|
| 0 | Endothelin Receptor Antagonist [EPC] | 51 |
| 1 | Prostacycline Vasodilator [EPC] | 44 |
| 2 | Kinase Inhibitor [EPC] | 33 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 31 |
| 4 | Phosphodiesterase 5 Inhibitor [EPC] | 30 |
| 5 | Provitamin D2 Compound [EPC] | 30 |
| 6 | Corticosteroid [EPC] | 28 |
| 7 | Benzodiazepine [EPC] | 25 |
| 8 | Osmotic Laxative [EPC] | 25 |
| 9 | Catecholamine [EPC] | 24 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Plasma Kallikrein Inhibitor [EPC] | 8 | 0.0033 |
| 1 | Human C1 Esterase Inhibitor [EPC] | 7 | 0.0018 |
| 2 | Enzyme Stabilizer [EPC] | 2 | 0.0017 |
| 3 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 4 | Glucosylceramide Synthase Inhibitor [EPC] | 3 | 0.0011 |
| 5 | Provitamin D2 Compound [EPC] | 30 | 0.0010 |
| 6 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 13 | 0.0010 |
| 7 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |
| 8 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 3 | 0.0009 |
| 9 | Pyruvate Kinase Activator [EPC] | 1 | 0.0008 |